Fendioksan
 | |
| Nazivi | |
|---|---|
| Preferisani IUPAC naziv 2-(2,6-Dimetoksifenoksi)-N-{[(2R,3R)-3-fenil-2,3-dihidro-1,4-benzodioksin-2-il]metil}etan-1-amin | |
| Identifikacija | |
| |
3D model (Jmol) |
|
| ChemSpider |
|
| |
| UNII |
|
SMILES
| |
| Svojstva | |
| C25H27NO5 | |
| Molarna masa | 421,49 g·mol−1 |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
| Reference infokutije | |
Fendioksan je antagonist α1-adrenergičkog receptora.[3]
Vidi još
- WB-4101
Reference
- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003. уреди
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ Quaglia, W; Pigini, M; Tayebati, SK; Piergentili, A; Giannella, M; Marucci, G; Melchiorre, C (1993). „Structure-activity relationships in 1,4-benzodioxan-related compounds. 4. Effect of aryl and alkyl substituents at position 3 on alpha-adrenoreceptor blocking activity”. Journal of Medicinal Chemistry. 36 (11): 1520—8. PMID 8098772. doi:10.1021/jm00063a002.
- п
- р
- у
Adrenergici
| |||||
|
| |||||||||||||||||||
Drugi | |||||||
|---|---|---|---|---|---|---|---|
| |||||||
